The company generated $125 million in annual net sales for Revuforj and $152 million for Niktimvo in the first 11 months.

AbbVie Inc. (NYSE:ABBV) is a global biopharmaceutical company focused on discovering and developing targeted therapies for ...

Summit Therapeutics Inc. (NASDAQ:SMMT) is one of the best cancer stocks to invest in now. On February 23, Summit Therapeutics ...

Guardant Health Inc. (NASDAQ:GH) is one of the best cancer stocks to invest in now. On February 23, Guardant Health Inc.

Cogent Biosciences Inc. (NASDAQ:COGT) is one of the best cancer stocks to invest in now. On February 17, CEO Andrew Robbins ...

Gold stocks have been on a tear over the past year, with the precious metal smashing records on its way to record highs.

Nuvation Bio Inc. (NYSE:NUVB) is one of the best cancer stocks to invest in now. On February 9, Nuvation Bio Inc.

On February 18, 2026, SGH and Steel Dynamics, Inc. (NASDAQ:STLD) announced that they had presented a new Non-Binding ...

On February 26, 2026, H.C. Wainwright raised the price target on United Therapeutics Corporation (NASDAQ:UTHR) from $525 to ...

On February 17, 2026, Barclays analyst Benjamin Budish reiterated a Buy rating on The Charles Schwab Corporation (NYSE:SCHW) ...